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Abstract—The calcium-binding proteins parvalbumin, calbi-
ndin D-28k, calretinin and calcineurin are present in subsets
of GABAergic gigantic calyciform presynaptic terminals of
the reticular thalamic nucleus (RTN). Previously it was hy-
pothesized that GABA and calcium-binding proteins includ-
ing parvalbumin are not only colocalized in the same neuron
subpopulation, but that GABA synthesis and parvalbumin
expression could be also genetically regulated by a common
mechanism. Moreover, parvalbumin expression levels could
inﬂuence GABA synthesis. For this, we analyzed GABA im-
munoreactivity in RTN gigantic calyciform presynaptic termi-
nals of parvalbumin–deﬁcient (PV/) mice. With respect to
GABA immunoreactivity we found no differences compared
to wild–type animals. However, using a polyclonal parvalbu-
min antibody raised against full-length rat muscle parvalbu-
min on brain sections of PV/ mice, we observed paradox-
ical parvalbumin immunoreactivity in partly varicose axons in
the diencephalon, mainly in the lamina medullaris externa
surrounding the thalamus. A detailed immunohistochemical,
biochemical and molecular biological analysis revealed this
immunoreactivity to be the result of an upregulation of onco-
modulin (OM), the mammalian beta isoform of parvalbumin in
PV/ mice. In addition, OM was present in a sparse sub-
population of neurons in the thalamus and in the dentate
gyrus. OM expression has not been observed before in neu-
rons of the mammalian brain; its expression was restricted to
outer hair cells in the organ of Corti. Our results indicate that
the absence of parvalbumin has no major effect on the
GABA-synthesizing system in RTN presynaptic terminals ex-
cluding a direct effect of parvalbumin on this regulation.
However, a likely homeostatic mechanism is induced result-
ing in the upregulation of OM in selected axons and neuronal
perikarya. Our results warrant further detailed investigations
on the putative role of OM in the brain.
Key words: reticular thalamic nucleus, thalamus, GABA,
parvalbumin, oncomodulin, regeneration.
At the level of gross anatomy, the reticular thalamic nu-
cleus (RTN) is a crescent-like structure, similar to a half-
eggshell, surrounding the lateral, superior and inferior as-
pects of the thalamus (Paxinos and Watson, 1982; Sidman
et al., 1971). The GABAergic RTN is a heterogeneous
structure, from cytoarchitectural, immunocytochemical,
electrophysiological and neuropharmacological viewpoints
alike (Steriade, 2001). It occupies a strategic position be-
tween speciﬁc nuclei of the thalamus and the cerebral
cortex (Steriade, 2001; Pinault, 2004), as a preferential
target of corticothalamic projections, located at the inter-
section of thalamo–cortical and cortico–thalamic path-
ways. The RTN is implied in almost all the functional mo-
dalities represented by its motor, somatosensory, visceral,
auditory, gustatory and limbic sectors (Shosaku et al., 1989).
In addition, the RTN plays an important part in transforming
nociception into pain (Gauriau and Bernard, 2002; Knyihar-
Csillik and Csillik, 2006), by regulating attention and distrac-
tion to potentially painful stimuli, functioning as a coincidence
detector (Kilmer, 2001). It has been shown by electrophysi-
ological and immunohistochemical studies by Knyihar-Csillik
et al. (2005) that a two-way trafﬁc between RTN and the
retrosplenial cortex is involved in the communication between
RTN and cerebral cortex.
In the large GABAergic calyciform presynaptic termi-
nals of RTN of the rat, several calcium-binding proteins
(CaBP) including parvalbumin (PV), calbindin D-28k, cal-
retinin and calcineurin have been observed (Csillik et al.,
2002a,b, 2004, 2005, 2006). At the light microscopic level,
RTN is characterized by an intense PV immunoreaction,
which originally was exclusively attributed to PV-immuno-
reactive neurons (Celio, 1990). Recent light- and electron
histochemical studies revealed however that some of the
structures, erroneously identiﬁed as nuclei, are in reality
cross-sections of large dendrites, while the PV-immunore-
active structures thought to correspond to nerve cell
perikarya, are in reality presynaptic dendraxonic terminals
(Csillik et al., 2002a, 2004). The PV-immunoreactive caly-
ciform presynaptic terminals contain GABA (Csillik et al.,
2005, 2006). This raised the question whether the GABA-
synthesizing enzyme GAD and calcium-binding proteins,
in particular the one most often present in these terminals,
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i.e. PV, are not only co-expressed in the same neuron
subpopulation, but whether they are also genetically reg-
ulated by a common mechanism. Furthermore, the obser-
vation that PV is almost exclusively expressed in GABAer-
gic neurons suggested that PV directly or indirectly could
affect the type or amount of neurotransmitter in the PV-
immunoreactive neuron population. In the cortex of PV/
mice, differences in the ﬁring properties of pyramidal cells
suggested that PV plays a key role in the regulation of local
inhibitory effects exerted by GABAergic interneurons on
pyramidal neurons (Schwaller et al., 2004, MCN). Further-
more, analysis of non-linear coupling of local ﬁeld potentials
indicated that absence of PV not only affects local neuronal
networks within the cortex, but might also affect interacting
sites that are distant from the recording electrodes but close
to each other, e.g. within the thalamus (Villa et al., 2000).
Thus, we decided to study by immunohistochemistry the
distribution of CaBPs in the RTN of PV knockout (PV/)
animals. Unexpectedly, in brain sections from PV/ mice
stained with one particular polyclonal anti-PV antiserum pro-
duced against full-length rat PV, “PV-immunoreactive” struc-
tures were detected. Both, structural details of these immu-
nopositive entities and the identity of the molecule giving rise
to this paradoxical PV staining, oncomodulin (OM), the beta
isoform of PV, are described in this report.
EXPERIMENTAL PROCEDURES
In these studies, the number of animals (rats/mice) was kept to a
minimum and efforts were taken to minimize the suffering; young
adult Wistar rats, young adult male mice of the C57Bl/6J strain and
homozygous parvalbumin-knockout (PV/) mice (Schwaller et al.,
1999; Vecellio et al., 2000) were analyzed. As compared to the
initial strain reported before (Schwaller et al., 1999) with a mixed
129Ola HsdC57Bl/6J genetic background, the animals used in
this study had been backcrossed to C57Bl/6J animals for at least
10 generations and are thus considered to be congenic with
C57Bl/6J mice (new name C57PV/). For the genotyping,
genomic DNA was isolated from tail biopsies that was followed by
PCR using primer pairs that were either speciﬁc for exon 3 (de-
leted in PV/ mice) or for part of the neomycin resistance
cassette (absent in PV/ mice). All mice were housed in groups
before use; they were adult (25–30 g) when used for experiments.
Care of the animals complied with the guidelines of the Hungarian
Ministry of Welfare and was in accordance with the European
Communities Council Directive (November 24, 1986; 86/609/
EEC), the NIH Guide for the Care and Use of Laboratory Animals
(NIH Publications No. 85–23, revised 1985) and the Guidelines for
Ethics in Animal Experiments, University of Szeged, Albert Szent-
Györgyi Medical School. After an i.p. injection with a lethal dose of
chloral hydrate, the animals were subjected to transcardial ﬁxation
with 4% formaldehyde, 0.5% glutaraldehyde in phosphate-buff-
ered saline (PBS). Brains were removed and processed in an
ascending series of sucrose, containing 4% formaldehyde.
PV immunohistochemistry
Serial cryostat sections, 20 m thick, were obtained in the para-
medial plane, comprising a thickness of 1–3 mm as measured
from the midsagittal plane. RTN was localized in mice, using the
parameters of the Sidman-Angevine-Pierce stereotactic atlas
1971, and in rats, using the Paxinos–Watson atlas (1982). On
free-ﬂoating sections or in sections adhered to Superfrost Ultra-
Plus specimen holders (Menzel, Braunschweig, Germany), PV
was detected immunohistochemically in rats and mice, by using a
rabbit polyclonal anti-mouse PV antibody raised against full-length
PV from rat (sc-7449, Santa Cruz, CA, USA) Preliminary experi-
ments showed best staining results with antibody dilutions of
1:2000–1:3500. Endogenous peroxidase activity was blocked by
0.3% hydrogen peroxide diluted in methanol, for 10 min, followed
by three successive rinses in 0.1 M phosphate buffer, pH 7.4.
Free-ﬂoating or adherent sections were pre-treated with blocking
serum (0.1–1.0 M PBS, 10% normal goat serum, 1% bovine
serum albumin (BSA) and 0.3% Triton X-100) on a shaker plate at
room temperature for 1 h, and then transferred into a solution
containing the primary antibody. Incubation was carried out at 4 °C
on a shaker for 36 h, followed by three rinses in 0.1 M phosphate
buffer. To detect the bound primary antibody, we used the avidin-
biotin-peroxidase method. Kits were obtained from Vector Labo-
ratories (Burlingame, CA, USA). The secondary antibody, biotin-
ylated anti-rabbit immunoglobulin was applied for 90 min at room
temperature. Three more rinses in 0.1 M phosphate buffer were
followed by incubation with the avidin-biotinylated peroxidase
complex for 60 min at room temperature. After three rinses in 0.1
M phosphate buffer, peroxidase activity was visualized by the
histochemical reaction involving diamino-benzidine-tetrahydro-
chloride (DAB) and hydrogen peroxide (3 l of 30% H2O2 in 10 ml
1% DAB). After three rinses in 0.1 M phosphate buffer, the sec-
tions were dehydrated in a graded series of alcohol, cleared in
xylene and coverslipped with Permount.
OM immunohistochemistry
An identical protocol was used for the detection of OM, the mam-
malian beta isoform of parvalbumin (MacManus, 1979), but as the
ﬁrst antibody the afﬁnity-puriﬁed polyclonal goat anti-OM antibody
(PV-beta, N-19, Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA) was used. This peptide antibody was raised against a region
in the N-terminus of human OM showing very low homology to
human PV. For control experiments, the blocking peptide sc-
7446P (Santa Cruz) was applied. Alternatively, the polyclonal
rabbit anti-OM antiserum OM3 from Swant (Bellinzona, Switzer-
land) raised against recombinant full-length rat OM was used.
Staining of sections with both sera yielded identical results. For all
antibodies, a series of experiments were carried out to demon-
strate the speciﬁcity of the antibody and included: (1) omission of
the ﬁrst speciﬁc antiserum; (2) incubation with normal rabbit or
mouse serum instead of incubation with the anti-PV or anti-OM
antibodies; (3) treatment according to the avidin-biotin complex
method, from which one of the steps had been omitted and (4)
preadsorption of the speciﬁc antibody with blocking peptides.
None of the specimens treated by one of the above methods
showed any speciﬁc immunoreactivity.
GABA immunoreactivity
GABA immunoreactivity was detected, applying the same protocol
but using a rabbit anti-GABA antiserum (Chemicon, Temecula,
CA, USA) at a dilution of 1:500.
Stereology
The number of calyciform terminals was determined in consecutive
coronal section series according to the method of West et al. (1991),
using a 100 oil immersion lens. Analysis was performed with the
aid of an Olympus microscope (Olympus, Tokyo, Japan) equipped
with a video camera and stepping motors. Counting frames were
superimposed on video images of the microscopic ﬁelds.
Western blot analysis
Western blot analysis was performed on tissue from the diencepha-
lons of brains of adult PV/ mice, according to the protocol of
Kamps and Sefton (1988), modiﬁed by Rogers et al. (1991) as
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follows. The tissue was homogenized with a Disperser T10 Basic
(IKA-Werke, Oberkochen, Germany) in 50 mM Tris buffer (pH 7.5)
containing 150 mM NaCl, 0.1% Igepal, 0.1% colic acid, 2 g/ml
leupeptin, 2 mM PMSF, 1 g/ml pepstatin, 2 mM EDTA and 0.1%
SDS. The homogenates were centrifuged at 12,000g for 10 min at
4 °C (Micro 200R, Hettich GmbH). The supernatants were used for
the detection of OM. The protein concentration was determined using
the bicinchoninic acid (BCA) Protein Assay Kit (Novagen®, 71285-3).
A sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) was carried out using a 13% gel (according to the
relative molecular size of OM: 12 kDa). The proteins were electro-
blotted onto a nitrocellulose membrane by using the BioRad Mini-
Protein II System at 300 mA for 1 h. The membrane was incubated
with 5% non-fat dried milk dissolved in TBS-Tween for 1 h. After
washing the samples in TBS-Tween (35 min), the blots were incu-
bated with a rabbit antibody to OM (Swant, Switzerland). Preliminary
experiments showed the best results at a 1:1000 working dilu-
tion. Incubation with the primary antibody was carried out in 1%
non-fat dried milk in 0.1% NaN3 overnight, at room temperature
under continuous shaking. After washing the samples in TBS-
Tween (35 min), the blots were incubated with the secondary
antibody (alkaline-phosphatase-conjugated anti-rabbit IgG) fol-
lowing the manufacturer’s instructions (1:2000). After washing
the samples in TBS-Tween (4x) and in TBS, the detection was
performed with BCIP/NBT (5-bromo-4-chloro-3-indolyl phos-
phate/nitro blue tetrazolium) tablets, obtained from Sigma, in
the dark room. After washing in sterile water, the membranes
were dried and scanned.
RNA isolation and RT-PCR
Brains derived from mice transcardially perfused with 0.9% NaCl
were homogenized in 1 ml of TRIZOL® reagent per 50–100 mg of
tissue using a homogenizer (Polytron) and were then incubated
for 5 min at RT. Chloroform (0.2 ml/ml of TRIZOL® reagent) was
added, tubes were vigorously shaken for 15 s and incubated at RT
for 2–3 min. After centrifugation (12,000g,15 min, 4 °C), the
aqueous phase was transferred to a new tube and the RNA was
precipitated by mixing with 0.5 ml isopropyl alcohol. The samples
were incubated at RT for 10 min, then centrifuged (12,000g, 10
min, 4 °C) and the supernatant aspired. The RNA pellet was
washed once with 1 ml ice cold (20 °C) 75% ethanol. The RNA
pellet was brieﬂy air-dried for 5–10 min. The RNA was dissolved
in 25 l RNase-free water and incubating for 10 min at 60 °C. The
total amount of RNA was then determined by measuring the
OD260nm. For the RT-PCR reaction, total RNA (2 g), 1 l random
hexamer primer (Promega) and H2O yielding a total volume of 12
l were mixed. The samples were heated to 70 °C for 5 min,
immediately chilled on ice and brieﬂy spun. Then the following
components were added: 4 l M-MLV reaction buffer 5x (Pro-
mega), 2 l dNTP-Mix (10 mM), 1 l recombinant RNasin® ribo-
nuclease inhibitor (Promega) and 1 l M-MLV reverse transcrip-
tase (Promega). After incubation for 60 min at 37 °C, 2 l of the RT
reaction mix were used for the PCR with the primer pairs speciﬁc
for mouse OM (mOM: forward: 5=-TGA GCA TCA CGG ACA TTC
TG-3=; reverse: 5=-ATC TTC CCA TCT CCA TCG TT-3=). The size
of the resulting PCR fragment is290 bp. The PCR amplicon was
loaded on a 0.8% agarose gel. The PCR fragment was then
cloned into the vector pGEM®-T Easy (Promega) and trans-
formed into competent E. coli Dh5. The plasmid DNA isolated
from three colonies was sequenced (Microsynth GmbH, Balgach,
Switzerland).
Double staining
Double staining of cells containing OM was performed with Neur-
exin 1alpha/beta siRNA obtained from Santa Cruz (sc-42050).
RESULTS
In control experiments performed in young adult Wistar albino
rats, PV and GABA immunoreactivity in the large calyciform
terminals of the RTN was clearly discernable (Fig. 1). The
Fig. 1. Parvalbumin (PV) and GABA in large calyciform presynaptic complexes of the reticular thalamic nucleus (RTN). (A) Parvalbumin immuno-
reactivity in calyciform presynaptic terminals in the RTN. Arrows point at PV–immunoreactive presynaptic elements; asterisks indicate PV-negative
dendritic proﬁles. Scale bar: 10 m. (B) GABA immunoreactivity present in the same structures as in (A). D indicates dendritic proﬁle; arrowhead
indicates a calyciform GABAergic terminal. Scale bar: 10 m. (C) Parvalbumin immunoreactivity evidenced at the level of electron microscopy; the
dendritic proﬁle (D) is surrounded by three PV-immunoreactive dendro-axonic elements (dA1, dA2, dA3). For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the Web version of this article.
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number of PV and GABA immunoreactive calyciform termi-
nals was 201017 in each hemisphere of the rat, as evi-
denced by stereological methods. Much lower numbers of
calyciform terminals were observed in the RTN of C57Bl/6J
mice (Fig. 2); quantitative analysis revealed the presence of
26212 PV and GABA-immunoreactive calyciform termi-
nals. While immunoreactivity for GABA appeared to be unal-
tered in these animals (Fig. 3A), a speciﬁc immunoreaction
for PV was absent in the gigantic calyciform terminals of
PV/ mice (Fig. 3B), in line with a complete absence of
PV-ir structures reported in the cortex of PV/ mice
(Schwaller et al., 2004). Totally unexpected, numerous, par-
tially varicose “PV-immunoreactive” axons appeared in vari-
ous parts of the diencephalon; some of them were localized
in the lamina medullaris externa, surrounding the thalamus
(Fig. 4A). The most likely explanation for these results was
Fig. 2. Presynaptic calyciform terminals in the RTN of a C57Bl/6J mouse. (A) Strong PV immunoreactivity is present in a presynaptic calyciform
terminal (arrow); the asterisk indicates a PV-negative dendritic proﬁle. Scale bar: 10 m. (B) A consecutive section was stained against GABA showing
strong immunoreactivity in a presynaptic calyciform terminal (arrow); the asterisk indicates a dendritic proﬁle. Scale bar: 10 m. For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the Web version of this article.
Fig. 3. Presynaptic calyciform terminals in the RTN of a PV/mouse. (A) GABA immunoreactivity of presynaptic calyciform terminals in the reticular
thalamic nucleus of a PV/ mouse is not different when compared to GABA-ir in a wild–type mouse (compare to Fig. 2B). An arrow points at one
of the GABA-immunoreactive calyciform terminals; asterisk indicates dendritic proﬁle. Scale bar: 10 m. (B) No speciﬁc PV signal was detected in
presynaptic calyciform terminals in the reticular thalamic nucleus of a PV/ mouse. The arrowhead points at the outlines of a PV-immunonegative
calyciform terminal; the faint contrast seen in this microphotograph is due to the selected parameters of microscopy (nearly closed diaphragm and
lowered condenser) and is not the result of unspeciﬁc staining. The asterisk indicates a dendritic proﬁle. Scale bar: 10 m. For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the Web version of this article.
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the presence of a molecule cross-reacting with the PV anti-
serum. On the basis of the large similarity between parval-
bumin (an alpha isoform) and OM (a beta isoform of the
parvalbumin subfamily of EF-hand CaBPs, for details see
Celio et al., 1996) that is 48% identity at the amino acid level,
OM was considered as the prime candidate leading to the
paradoxical PV staining. Thus we carried out a series of
experiments to verify that the observed immunoreactiv-
ity was due to OM expression. Axonal structures, similar
to those previously observed in PV/ mice with the
polyclonal PV antiserum were stained with the OM an-
tibody raised against the N-terminal OM-speciﬁc peptide
(Fig. 4B, C).
To ascertain that the observed immunoreactivity in
PV/ brains was due to expression of OM, a series of
experiments were carried out and the results are summa-
rized here. The immunoreactive structures were stained
with OM antibodies derived from two different sources; the
Fig. 4. (A) Bundles of oncomodulin (OM)-expressing axons (arrows) of the lamina medullaris external surrounding the thalamus (th) at low
magniﬁcation in the brain of a PV/ mouse. For the immunostaining in (AC) the OM antiserum N-19 sc-7446 (Santa Cruz) was used. Scale bar:
100 m. Individual OM-expressing axons, some of them varicose (B), others lacking varicosities (C) are depicted at higher magniﬁcation. In (D), similar
axonal structures can be seen in a specimen stained with the OM-speciﬁc antiserum OM3 (Swant). Scale bar for B–D: 10 m. For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the Web version of this article.
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above-mentioned OM peptide antibody (Santa Cruz) and a
polyclonal rabbit antiserum raised against full-length rat
OM (Swant; for details, see Material and Methods). The
axonal structures stained with the antiserum OM3 (Swant)
(Fig. 4D) were asbsolutely identical to those seen with the
antibody N-19 sc-7446 (Santa Cruz) for the visualization of
OM (Fig. 4B, C).
Furthermore, while immunoreactivity persisted after
preincubation with the PV-speciﬁc blocking peptide sc-
7449P (Fig. 5A), speciﬁc staining with the OM peptide
antiserum N-19 sc-7446 completely disappeared, when
the primary antibody solution was preincubated with the
OM-speciﬁc blocking peptide sc-7446 P (Fig. 5B).
Speciﬁc OM expression was not restricted to OM-im-
munopositive processes or ﬁber bundles, but was also
detected in perikarya of cells scattered in the diencephalon
(Fig. 6A–D), the cytological identity of which could not be
unambiguously ascertained; accordingly, these may be
neuroblasts, macrophages or possibly cells of neuroendo-
crine origin as well. OM appeared in the processes of
these cells in a vesicular or granular form (Fig. 6A, B)
resembling those reported by Yin et al. (2006). Apparently,
the vesicles/granules are sometimes conﬁned to or trans-
formed into varicosities of nerve-ﬁbers (Fig. 6C). OM con-
taining vesicles and/or granules were present in the cellu-
lar cytoplasm of certain cells, where the immunoreactivity
was accumulated in clusters of vesicles/granules within the
perikaryon (Fig. 6D). In order to ascertain whether or not,
OM-expressing cells belong to the cell line of neuroblasts/
neurons, double staining with the neuron-speciﬁc Neurexin
1alpha/beta siRNA was performed. In some of the OM-
immunopositive cells, the OM immunoreactivity colocal-
ized with the Neurexin staining (Fig. 6E), whereas in the
majority of OM immunopositive cells Neurexin staining was
not observed. Thus, this indicates that OM immunoreac-
tivity was present in at least two different cell populations,
one likely of neuronal origin (Neurexin 1alpha/beta-positive
cells).
Western blot analysis of diencephalon homogenates
from PV/ mice with the OM-speciﬁc antibody (Santa
Cruz) yielded a weak band of approximately 12 kDa cor-
responding to the calculated Mr of 12,260 Da for mouse
OM (Fig. 7A). Furthermore, an OM-speciﬁc PCR using
total RNA isolated from PV/ brains resulted in a speciﬁc
band of the expected size of 290 bp (Fig. 7B). A much
weaker signal was also seen with RNA isolated from the
brains of C57Bl/6J wild–type mice suggesting minute
amounts of OM mRNA may be also present in brains of
wild–type mice.
DISCUSSION
The unchanged GABA staining in the RTN of PV/ mice
is a strong indication that PV does not exert a signiﬁcant
control on GABA expression in the diencephalon. Evi-
dently, subtle differences in GABA distribution and/or ex-
pression could not be determined by the methods used
here and further electrophysiological analysis of the RTN
of PV/ mice needs to be carried out. Whether a link
between GABA and calcium handling systems (e.g. PV)
exists also in other parts of the central nervous system
(CNS) (e.g. PMCA2 in GABAergic terminals of PV inter-
neurons in the cortex, as reported by Burette et al., 2009,
or in the amygdala, as shown by McDonald and Mascagni,
2001), where GABA colocalizes with PV, remains to be
shown.
OM, the beta isoform of parvalbumin, discovered by
MacManus (1979) and by Brewer and MacManus (1987)
was known until now to be present in adult mammals only
in the organ of Corti of the inner ear, in particular in the
outer hair cells (Thalmann et al., 1995; Sakaguchi et al.,
1998, Hackney et al., 2005). According to our present
studies, an extensive system of OM-immunoreactive ax-
ons is present in the diencephalon of PV-deﬁcient animals.
These OM-immunoreactive axons were present, inter alia,
in the lamina medullaris externa of the thalamus of PV-
deﬁcient animals. Remarkably, in wild–type animals only
the presence of met-enkephalin-immunopositive nerve-ﬁ-
bers has been reported in the lamina medullaris externa so
far (Conrath et al., 1986). The fact that the OM-immuno-
reactive ﬁbers had not been previously observed in wild–
type mice may be due to either extremely low expression
levels or the absence of any OM expression at the protein
Fig. 5. (A). Bundle of OM-ir axons in specimen from a PV/ mouse
stained with the OM speciﬁc peptide antibody sc-7446 (B). In a serial
section pretreated with the OM blocking peptide sc-7446P, no speciﬁc
immunoreaction was observed in nerve ﬁbers. The OM immunoreac-
tivity persisted when the serial section was incubated with the parval-
bumin blocking peptide sc-7449P. Scale bar: 10 m. For interpretation
of the references to color in this ﬁgure legend, the reader is referred to
the Web version of this article.
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level. However, our RT-PCR results indicate that also in
C57Bl/6J mice, low levels of OM mRNA are present in the
brain. In contrast to our initial hypothesis that the neuro-
transmitter (GABA) and PV could be regulated in a similar
manner, we found no evidence that the absence of PV in
PV/ mice entailed a change in GABA, since GABA
Fig. 6. (A, B): Expression of OM in cellular processes in the thalamus of a PV/ mouse. Expression is limited to vesicles/granules (arrows) outlining the
processes of the depicted cells originating from the thalamus. In (C), vesicles/granules are localized to varicosities of nerve-ﬁbers (arrows heads), proceeding
amongst immunonegative cell bodies (D): Cell body giving raise to OM immunopositive axons in the thalamus of a PV/ mouse. Arrowhead points at
accumulation of OM-immunoreactive vesicles/granules in the perikaryon. N indicates nucleus. (E): A cell close to the hilus of the dentate gyrus. Arrow points
at double staining for OM (brown) and the neuronal marker Neurexin 1alpha/beta (violet) suggesting that the cell may belong to the neuroblastic cell line.
Scale bar: 10 m. For interpretation of the references to color in this ﬁgure legend, the reader is referred to the Web version of this article.
Fig. 7. (A) Western blot analysis of OM in a tissue homogenate isolated from the diencephalon of a PV/ mouse. The speciﬁc band (arrow)
corresponding to OM (left lane) has a relative molecular mass of 12 kDa estimated from the sizes of marker proteins contained in the prestained
protein ladder (right lane). The upper weaker bands in the left lane are trace amounts of the ladder proteins. (B) Agarose gel (0.8%) of PCR amplicons
derived from reverse-transcribed RNA isolated from the diencephalons of C57Bl/6J wild–type and PV/ mice. Lanes: (1) 100 bp DNA Ladder
(Promega); the position of the 300 bp band is marked by arrow. (2) positive control (290 bp) using mouse OM cDNA in vector pGEM as PCR template.
(3) negative control (H2O only, no RT product added). (4) RT-PCR product from the diencephalon of a C57-PV/ mouse. (5) RT-PCR product from
a C57Bl/6J wild–type mouse. Note that a very faint band of the correct size (290 bp) is present in samples of the diencephalon of wild–type mice.
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immunoreaction of large calyciform presynaptic terminals
was essentially unaffected.
Since our initial observation of a paradoxical PV immu-
noreactivity in the PV/ mice was based on the cross-
reactivity of the applied PV antibody with its closest family
member of the EF-hand family of CaBPs, namely OM, we
performed several experiments to ascertain the identity of
the antigen detected by the antibodies used in this study.
In the report by Fu et al. (2004), the speciﬁcity of the
antibody sc-7449 for alpha-PV (C-19, Santa Cruz) was
demonstrated. The speciﬁcity of the antibody sc-7446
used for the detection of OM (OCM N-19, Santa Cruz) is
described in the paper of Devarajan et al. (2005). And
ﬁnally, the speciﬁcity of the polyclonal OM antibody OM3
(distributed by Swant, Bellinzona, Switzerland) was re-
ported by Rentsch et al. (2006). The PV immunogen sc-
7449P shares 56% identity with protein phosphatase 3
regulatory subunit, beta isoform: for a short peptide this
homology is considered to be too low to cross-react with
any known protein, since cross-reactivity is predicted to
occur at 85% or greater sequence identity (L. Hatt, Santa
Cruz Biotechnology, CA, USA, personal communication).
The OM peptide to produce the antibody sc-7446 does not
share any signiﬁcant sequence identity with any known
protein. Thus, the blocking peptides sc-7449P to neutralize
the PV antibody and sc-7446P to neutralize the OM anti-
body were designed speciﬁcally for each antibody and
share the same low sequence identity towards the other
peptide. Also for the OM speciﬁc antibody OM3 from
Swant, no crossreactivity for PV has been reported to our
knowledge. In contrast, the polyclonal PV antiserum ini-
tially used in our study, cross-reacts with the beta parval-
bumin, OM.
While PV is a mobile cytosolic CaBP und thus consid-
ered to be distributed homogenously throughout the cells
in which it is expressed, the staining for OM observed in
the brain of PV/ mice appeared not homogenous. OM-
immunoreactivity was seen in granular/vesicular structures
in cell processes (Fig. 6A, B) or in the periphery of cell
bodies. Also OM-immunoreactivity in ﬁber bundles ap-
peared to be relatively non-homogenous (e.g. Fig. 5A).
This suggests that OM could be enclosed in compartments
within these cells (vesicles/granules), which would be in
line with the idea that OM may be secreted and have
extracellular functions (see below). On the other hand,
recent structural data on OM, most importantly calcium-
induced conformational changes, indicate that this protein
could also have calcium sensor functions, possibly also
inside cells including nerve-ﬁbers (for details, see
Schwaller, 2009 and below). Also in situ hybridization ex-
periments, which are now in progress using the plasmid
DNA mentioned in the “Experimental procedure” chapter,
and to be published in a forthcoming paper (personal
communication of Prof. Karoly Gulya et al., Albert Szent-
Györgyi Medical School, Szeged, Hungary) seem to
strenghten our case.
Besides the nerve ﬁbers, we also detected several
OM-immunoreactive cellular elements scattered through-
out the thalamus and the dentate gyrus. According to
recent results, extracellular OM produced by macrophages
may promote axonal elongation and regeneration (Yin et
al., 2006); this theory was supported by the studies of
Müller et al. (2007, 2009) and Benowitz and Yin (2008).
However, more recent studies raise questions about the
macrophage origin of OM (Hauk et al., 2008; Charalam-
bous et al., 2008) and it remains to be demonstrated
whether extracellular OM is able to promote axonal out-
growth or axonal regeneration also under normal condi-
tions (Taylor et al., 2009). According to our studies, based
on double staining with the marker Neurexin, some of the
OM-expressing cells close to the gyrus dentatus of PV/
mice belong to the neuroblastic cell line or could even
correspond to neurons. The dentate gyrus of the hip-
pocampus is one of the brain regions, where prominent
neurogenesis is reported to occur in adult mammals (Kem-
permann et al., 2004) although, in the view of other authors
(Rakic, 2006; Breunig et al., 2007) adult neuro-neogene-
sis, in particular in the human neocortex, is controversial.
Since changes in neurogenesis have been reported in
several genetically-modiﬁed mouse strains (Li and Ames,
2008; Kuhn et al., 2005), it will be challenging to see
whether the selective upregulation of OM in speciﬁc cells in
the dentate gyrus is connected to altered neurogenesis in
PV/ mice. Assuming a putative neurotrophic role of
extracellular OM derived from either macrophages or from
OM-expressing neurons, i.e. to induce axonal regeneration
in the adult CNS, this presents an unsurpassed challenge
for clinical neurologists and neurosurgeons alike.
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